Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. sophomore Avg
|
New words:
abiraterone, accredited, adrenergic, agonist, antagonist, antitubulin, bisindole, blocking, castration, cis, decision, docetaxel, entirety, enzalutamide, estrogen, exact, exempt, Exhibit, foregoing, fourth, human, inhibition, intravaginal, latency, muscarinic, Nonemployee, pipeline, promulgated, receptor, referenced, resignation, retirement, safer, sex, shrink, specialty, STI, super, text, toxicity, Trademark, transmission, triple, unable, unmet
Filing tables
Filing exhibits
Related press release
Associated VERU transcripts
VERU similar filings
Filing view
External links